Bayer said positive synergy effects from the planned takeover of U.S. seeds maker Monsanto would be about $300 million below its previous target because it will sell more businesses than initially expected to get antitrust approval.
Bayer Chief Executive Werner Baumann again threw his weight behind the deal, despite higher antitrust hurdles and delays in the regulatory reviews, speaking to shareholders at the annual general meeting on Friday.
“I’m convinced that this acquisition has very great potential for creating value for our company, our stockholders and our customers,” Baumann said, adding he expected the deal to be approved and closed in the near future.
If the deal is not closed by June 14, Monsanto could withdraw from the takeover agreement and seek a higher price.
The last major hurdle to clear is the go-ahead from U.S. regulators for the deal, worth $62.5 billion including debt, but Bayer has already come to an agreement in principle on the terms of approval with the Department of Justice.
It has agreed to sell assets, which include seed, crop chemicals and digital farming activities, with revenues of 2.2 billion euro ($2.6 billion) for 7.6 billion euros to rival BASF.
Combining with takeover target Monsanto will have synergy effects of about $1.2 billion on adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) from 2022, Bayer said – less than the $1.5 billion targeted when the transaction was agreed in September 2016.
By Patricia Weiss
Source: Reuters
After a six-year break, Interpack – Europe’s largest packaging trade fair – made a highly anticipated return in 2023, providing attendees with a comprehensive overview of the latest packaging trends and advancements. This year’s event took place in Düsseldorf, Germany, from 4 to 10 May.
Processing equipment and solution provider Hillenbrand has announced plans to acquire Schenck Process Food and Performance Materials (FPM) for around $730 million. FPM, a portfolio company of private investment firm Blackstone, develops, manufactures, markets and sells a full range of solutions, products and systems for the food, chemicals and performance industries.
Asian dairy company Yili Group is strengthening its partnership with Sidel by installing the equipment provider’s Aseptic Lab filler to research and test product designs. Sidel’s Aseptic Lab filler is said to be compact and customized to meet Yili’s R&D needs for test runs consisting of a small number of bottles with different shapes and sizes.
